Dr Marc Mansour
Guest ContributorMarch 21, 2016
Dr Marc Mansour has stepped down as CEO of Halifax-based Immunovaccine Inc after 14 years. Mansour will be replaced in an acting capacity while the firm conducts a search for his replacement. Acting CEO Frederic Ors joined Immunovaccine last year from Medicago Inc (now a subsidiary of Mitsubishi) with responsibility for licencing, intellectual property and communications....
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 1 free article remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.